COVID-19 Impact on Global OTC Drug, Market Insights and Forecast to 2026
OTC Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global OTC Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the OTC Drug market is segmented into
The OTC Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the OTC Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and OTC Drug Market Share Analysis
OTC Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in OTC Drug business, the date to enter into the OTC Drug market, OTC Drug product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the OTC Drug market is segmented into
- Class A
- Class B
- Hospital
- Clinic
- Household
The OTC Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the OTC Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and OTC Drug Market Share Analysis
OTC Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in OTC Drug business, the date to enter into the OTC Drug market, OTC Drug product introduction, recent developments, etc.
The major vendors covered:
- Bayer HealthCare
- GlaxoSmithKline (GSK)
- Johnson&Johnson
- Pfizer
- Sanofi
- AstraZeneca
- BioGaia
- Bristol Myers Squibb
- Bukwang Pharmaceutica
- Chr. Hansen
- Cipla
- CoLucid
- Daiichi Sankyo
- Friggs
- DSM
- Eisai
- Eli Lilly
- Herbalife
- Euradite
1 STUDY COVERAGE
1.1 OTC Drug Product Introduction
1.2 Market Segments
1.3 Key OTC Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global OTC Drug Market Size Growth Rate by Type
1.4.2 Class A
1.4.3 Class B
1.5 Market by Application
1.5.1 Global OTC Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Household
1.6 Coronavirus Disease 2019 (Covid-19): OTC Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the OTC Drug Industry
1.6.1.1 OTC Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and OTC Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for OTC Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global OTC Drug Market Size Estimates and Forecasts
2.1.1 Global OTC Drug Revenue 2015-2026
2.1.2 Global OTC Drug Sales 2015-2026
2.2 OTC Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global OTC Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global OTC Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OTC DRUG COMPETITOR LANDSCAPE BY PLAYERS
3.1 OTC Drug Sales by Manufacturers
3.1.1 OTC Drug Sales by Manufacturers (2015-2020)
3.1.2 OTC Drug Sales Market Share by Manufacturers (2015-2020)
3.2 OTC Drug Revenue by Manufacturers
3.2.1 OTC Drug Revenue by Manufacturers (2015-2020)
3.2.2 OTC Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global OTC Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by OTC Drug Revenue in 2019
3.2.5 Global OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 OTC Drug Price by Manufacturers
3.4 OTC Drug Manufacturing Base Distribution, Product Types
3.4.1 OTC Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers OTC Drug Product Type
3.4.3 Date of International Manufacturers Enter into OTC Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global OTC Drug Market Size by Type (2015-2020)
4.1.1 Global OTC Drug Sales by Type (2015-2020)
4.1.2 Global OTC Drug Revenue by Type (2015-2020)
4.1.3 OTC Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global OTC Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global OTC Drug Sales Forecast by Type (2021-2026)
4.2.2 Global OTC Drug Revenue Forecast by Type (2021-2026)
4.2.3 OTC Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global OTC Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global OTC Drug Market Size by Application (2015-2020)
5.1.1 Global OTC Drug Sales by Application (2015-2020)
5.1.2 Global OTC Drug Revenue by Application (2015-2020)
5.1.3 OTC Drug Price by Application (2015-2020)
5.2 OTC Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global OTC Drug Sales Forecast by Application (2021-2026)
5.2.2 Global OTC Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global OTC Drug Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America OTC Drug by Country
6.1.1 North America OTC Drug Sales by Country
6.1.2 North America OTC Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America OTC Drug Market Facts & Figures by Type
6.3 North America OTC Drug Market Facts & Figures by Application
7 EUROPE
7.1 Europe OTC Drug by Country
7.1.1 Europe OTC Drug Sales by Country
7.1.2 Europe OTC Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe OTC Drug Market Facts & Figures by Type
7.3 Europe OTC Drug Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific OTC Drug by Region
8.1.1 Asia Pacific OTC Drug Sales by Region
8.1.2 Asia Pacific OTC Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific OTC Drug Market Facts & Figures by Type
8.3 Asia Pacific OTC Drug Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America OTC Drug by Country
9.1.1 Latin America OTC Drug Sales by Country
9.1.2 Latin America OTC Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America OTC Drug Market Facts & Figures by Type
9.3 Central & South America OTC Drug Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa OTC Drug by Country
10.1.1 Middle East and Africa OTC Drug Sales by Country
10.1.2 Middle East and Africa OTC Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa OTC Drug Market Facts & Figures by Type
10.3 Middle East and Africa OTC Drug Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Corporation Information
11.1.2 Bayer HealthCare Description, Business Overview and Total Revenue
11.1.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer HealthCare OTC Drug Products Offered
11.1.5 Bayer HealthCare Recent Development
11.2 GlaxoSmithKline (GSK)
11.2.1 GlaxoSmithKline (GSK) Corporation Information
11.2.2 GlaxoSmithKline (GSK) Description, Business Overview and Total Revenue
11.2.3 GlaxoSmithKline (GSK) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline (GSK) OTC Drug Products Offered
11.2.5 GlaxoSmithKline (GSK) Recent Development
11.3 Johnson&Johnson
11.3.1 Johnson&Johnson Corporation Information
11.3.2 Johnson&Johnson Description, Business Overview and Total Revenue
11.3.3 Johnson&Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson&Johnson OTC Drug Products Offered
11.3.5 Johnson&Johnson Recent Development
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description, Business Overview and Total Revenue
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer OTC Drug Products Offered
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description, Business Overview and Total Revenue
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi OTC Drug Products Offered
11.5.5 Sanofi Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Corporation Information
11.6.2 AstraZeneca Description, Business Overview and Total Revenue
11.6.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AstraZeneca OTC Drug Products Offered
11.6.5 AstraZeneca Recent Development
11.7 BioGaia
11.7.1 BioGaia Corporation Information
11.7.2 BioGaia Description, Business Overview and Total Revenue
11.7.3 BioGaia Sales, Revenue and Gross Margin (2015-2020)
11.7.4 BioGaia OTC Drug Products Offered
11.7.5 BioGaia Recent Development
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Corporation Information
11.8.2 Bristol Myers Squibb Description, Business Overview and Total Revenue
11.8.3 Bristol Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bristol Myers Squibb OTC Drug Products Offered
11.8.5 Bristol Myers Squibb Recent Development
11.9 Bukwang Pharmaceutica
11.9.1 Bukwang Pharmaceutica Corporation Information
11.9.2 Bukwang Pharmaceutica Description, Business Overview and Total Revenue
11.9.3 Bukwang Pharmaceutica Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bukwang Pharmaceutica OTC Drug Products Offered
11.9.5 Bukwang Pharmaceutica Recent Development
11.10 Chr. Hansen
11.10.1 Chr. Hansen Corporation Information
11.10.2 Chr. Hansen Description, Business Overview and Total Revenue
11.10.3 Chr. Hansen Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Chr. Hansen OTC Drug Products Offered
11.10.5 Chr. Hansen Recent Development
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Corporation Information
11.1.2 Bayer HealthCare Description, Business Overview and Total Revenue
11.1.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer HealthCare OTC Drug Products Offered
11.1.5 Bayer HealthCare Recent Development
11.12 CoLucid
11.12.1 CoLucid Corporation Information
11.12.2 CoLucid Description, Business Overview and Total Revenue
11.12.3 CoLucid Sales, Revenue and Gross Margin (2015-2020)
11.12.4 CoLucid Products Offered
11.12.5 CoLucid Recent Development
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Corporation Information
11.13.2 Daiichi Sankyo Description, Business Overview and Total Revenue
11.13.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Daiichi Sankyo Products Offered
11.13.5 Daiichi Sankyo Recent Development
11.14 Friggs
11.14.1 Friggs Corporation Information
11.14.2 Friggs Description, Business Overview and Total Revenue
11.14.3 Friggs Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Friggs Products Offered
11.14.5 Friggs Recent Development
11.15 DSM
11.15.1 DSM Corporation Information
11.15.2 DSM Description, Business Overview and Total Revenue
11.15.3 DSM Sales, Revenue and Gross Margin (2015-2020)
11.15.4 DSM Products Offered
11.15.5 DSM Recent Development
11.16 Eisai
11.16.1 Eisai Corporation Information
11.16.2 Eisai Description, Business Overview and Total Revenue
11.16.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Eisai Products Offered
11.16.5 Eisai Recent Development
11.17 Eli Lilly
11.17.1 Eli Lilly Corporation Information
11.17.2 Eli Lilly Description, Business Overview and Total Revenue
11.17.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Eli Lilly Products Offered
11.17.5 Eli Lilly Recent Development
11.18 Herbalife
11.18.1 Herbalife Corporation Information
11.18.2 Herbalife Description, Business Overview and Total Revenue
11.18.3 Herbalife Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Herbalife Products Offered
11.18.5 Herbalife Recent Development
11.19 Euradite
11.19.1 Euradite Corporation Information
11.19.2 Euradite Description, Business Overview and Total Revenue
11.19.3 Euradite Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Euradite Products Offered
11.19.5 Euradite Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 OTC Drug Market Estimates and Projections by Region
12.1.1 Global OTC Drug Sales Forecast by Regions 2021-2026
12.1.2 Global OTC Drug Revenue Forecast by Regions 2021-2026
12.2 North America OTC Drug Market Size Forecast (2021-2026)
12.2.1 North America: OTC Drug Sales Forecast (2021-2026)
12.2.2 North America: OTC Drug Revenue Forecast (2021-2026)
12.2.3 North America: OTC Drug Market Size Forecast by Country (2021-2026)
12.3 Europe OTC Drug Market Size Forecast (2021-2026)
12.3.1 Europe: OTC Drug Sales Forecast (2021-2026)
12.3.2 Europe: OTC Drug Revenue Forecast (2021-2026)
12.3.3 Europe: OTC Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific OTC Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: OTC Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: OTC Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: OTC Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America OTC Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: OTC Drug Sales Forecast (2021-2026)
12.5.2 Latin America: OTC Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: OTC Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa OTC Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: OTC Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: OTC Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: OTC Drug Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key OTC Drug Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 OTC Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 OTC Drug Product Introduction
1.2 Market Segments
1.3 Key OTC Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global OTC Drug Market Size Growth Rate by Type
1.4.2 Class A
1.4.3 Class B
1.5 Market by Application
1.5.1 Global OTC Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Household
1.6 Coronavirus Disease 2019 (Covid-19): OTC Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the OTC Drug Industry
1.6.1.1 OTC Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and OTC Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for OTC Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global OTC Drug Market Size Estimates and Forecasts
2.1.1 Global OTC Drug Revenue 2015-2026
2.1.2 Global OTC Drug Sales 2015-2026
2.2 OTC Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global OTC Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global OTC Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OTC DRUG COMPETITOR LANDSCAPE BY PLAYERS
3.1 OTC Drug Sales by Manufacturers
3.1.1 OTC Drug Sales by Manufacturers (2015-2020)
3.1.2 OTC Drug Sales Market Share by Manufacturers (2015-2020)
3.2 OTC Drug Revenue by Manufacturers
3.2.1 OTC Drug Revenue by Manufacturers (2015-2020)
3.2.2 OTC Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global OTC Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by OTC Drug Revenue in 2019
3.2.5 Global OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 OTC Drug Price by Manufacturers
3.4 OTC Drug Manufacturing Base Distribution, Product Types
3.4.1 OTC Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers OTC Drug Product Type
3.4.3 Date of International Manufacturers Enter into OTC Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global OTC Drug Market Size by Type (2015-2020)
4.1.1 Global OTC Drug Sales by Type (2015-2020)
4.1.2 Global OTC Drug Revenue by Type (2015-2020)
4.1.3 OTC Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global OTC Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global OTC Drug Sales Forecast by Type (2021-2026)
4.2.2 Global OTC Drug Revenue Forecast by Type (2021-2026)
4.2.3 OTC Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global OTC Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global OTC Drug Market Size by Application (2015-2020)
5.1.1 Global OTC Drug Sales by Application (2015-2020)
5.1.2 Global OTC Drug Revenue by Application (2015-2020)
5.1.3 OTC Drug Price by Application (2015-2020)
5.2 OTC Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global OTC Drug Sales Forecast by Application (2021-2026)
5.2.2 Global OTC Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global OTC Drug Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America OTC Drug by Country
6.1.1 North America OTC Drug Sales by Country
6.1.2 North America OTC Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America OTC Drug Market Facts & Figures by Type
6.3 North America OTC Drug Market Facts & Figures by Application
7 EUROPE
7.1 Europe OTC Drug by Country
7.1.1 Europe OTC Drug Sales by Country
7.1.2 Europe OTC Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe OTC Drug Market Facts & Figures by Type
7.3 Europe OTC Drug Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific OTC Drug by Region
8.1.1 Asia Pacific OTC Drug Sales by Region
8.1.2 Asia Pacific OTC Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific OTC Drug Market Facts & Figures by Type
8.3 Asia Pacific OTC Drug Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America OTC Drug by Country
9.1.1 Latin America OTC Drug Sales by Country
9.1.2 Latin America OTC Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America OTC Drug Market Facts & Figures by Type
9.3 Central & South America OTC Drug Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa OTC Drug by Country
10.1.1 Middle East and Africa OTC Drug Sales by Country
10.1.2 Middle East and Africa OTC Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa OTC Drug Market Facts & Figures by Type
10.3 Middle East and Africa OTC Drug Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Corporation Information
11.1.2 Bayer HealthCare Description, Business Overview and Total Revenue
11.1.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer HealthCare OTC Drug Products Offered
11.1.5 Bayer HealthCare Recent Development
11.2 GlaxoSmithKline (GSK)
11.2.1 GlaxoSmithKline (GSK) Corporation Information
11.2.2 GlaxoSmithKline (GSK) Description, Business Overview and Total Revenue
11.2.3 GlaxoSmithKline (GSK) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline (GSK) OTC Drug Products Offered
11.2.5 GlaxoSmithKline (GSK) Recent Development
11.3 Johnson&Johnson
11.3.1 Johnson&Johnson Corporation Information
11.3.2 Johnson&Johnson Description, Business Overview and Total Revenue
11.3.3 Johnson&Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson&Johnson OTC Drug Products Offered
11.3.5 Johnson&Johnson Recent Development
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description, Business Overview and Total Revenue
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer OTC Drug Products Offered
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description, Business Overview and Total Revenue
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi OTC Drug Products Offered
11.5.5 Sanofi Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Corporation Information
11.6.2 AstraZeneca Description, Business Overview and Total Revenue
11.6.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AstraZeneca OTC Drug Products Offered
11.6.5 AstraZeneca Recent Development
11.7 BioGaia
11.7.1 BioGaia Corporation Information
11.7.2 BioGaia Description, Business Overview and Total Revenue
11.7.3 BioGaia Sales, Revenue and Gross Margin (2015-2020)
11.7.4 BioGaia OTC Drug Products Offered
11.7.5 BioGaia Recent Development
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Corporation Information
11.8.2 Bristol Myers Squibb Description, Business Overview and Total Revenue
11.8.3 Bristol Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bristol Myers Squibb OTC Drug Products Offered
11.8.5 Bristol Myers Squibb Recent Development
11.9 Bukwang Pharmaceutica
11.9.1 Bukwang Pharmaceutica Corporation Information
11.9.2 Bukwang Pharmaceutica Description, Business Overview and Total Revenue
11.9.3 Bukwang Pharmaceutica Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bukwang Pharmaceutica OTC Drug Products Offered
11.9.5 Bukwang Pharmaceutica Recent Development
11.10 Chr. Hansen
11.10.1 Chr. Hansen Corporation Information
11.10.2 Chr. Hansen Description, Business Overview and Total Revenue
11.10.3 Chr. Hansen Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Chr. Hansen OTC Drug Products Offered
11.10.5 Chr. Hansen Recent Development
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Corporation Information
11.1.2 Bayer HealthCare Description, Business Overview and Total Revenue
11.1.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer HealthCare OTC Drug Products Offered
11.1.5 Bayer HealthCare Recent Development
11.12 CoLucid
11.12.1 CoLucid Corporation Information
11.12.2 CoLucid Description, Business Overview and Total Revenue
11.12.3 CoLucid Sales, Revenue and Gross Margin (2015-2020)
11.12.4 CoLucid Products Offered
11.12.5 CoLucid Recent Development
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Corporation Information
11.13.2 Daiichi Sankyo Description, Business Overview and Total Revenue
11.13.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Daiichi Sankyo Products Offered
11.13.5 Daiichi Sankyo Recent Development
11.14 Friggs
11.14.1 Friggs Corporation Information
11.14.2 Friggs Description, Business Overview and Total Revenue
11.14.3 Friggs Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Friggs Products Offered
11.14.5 Friggs Recent Development
11.15 DSM
11.15.1 DSM Corporation Information
11.15.2 DSM Description, Business Overview and Total Revenue
11.15.3 DSM Sales, Revenue and Gross Margin (2015-2020)
11.15.4 DSM Products Offered
11.15.5 DSM Recent Development
11.16 Eisai
11.16.1 Eisai Corporation Information
11.16.2 Eisai Description, Business Overview and Total Revenue
11.16.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Eisai Products Offered
11.16.5 Eisai Recent Development
11.17 Eli Lilly
11.17.1 Eli Lilly Corporation Information
11.17.2 Eli Lilly Description, Business Overview and Total Revenue
11.17.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Eli Lilly Products Offered
11.17.5 Eli Lilly Recent Development
11.18 Herbalife
11.18.1 Herbalife Corporation Information
11.18.2 Herbalife Description, Business Overview and Total Revenue
11.18.3 Herbalife Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Herbalife Products Offered
11.18.5 Herbalife Recent Development
11.19 Euradite
11.19.1 Euradite Corporation Information
11.19.2 Euradite Description, Business Overview and Total Revenue
11.19.3 Euradite Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Euradite Products Offered
11.19.5 Euradite Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 OTC Drug Market Estimates and Projections by Region
12.1.1 Global OTC Drug Sales Forecast by Regions 2021-2026
12.1.2 Global OTC Drug Revenue Forecast by Regions 2021-2026
12.2 North America OTC Drug Market Size Forecast (2021-2026)
12.2.1 North America: OTC Drug Sales Forecast (2021-2026)
12.2.2 North America: OTC Drug Revenue Forecast (2021-2026)
12.2.3 North America: OTC Drug Market Size Forecast by Country (2021-2026)
12.3 Europe OTC Drug Market Size Forecast (2021-2026)
12.3.1 Europe: OTC Drug Sales Forecast (2021-2026)
12.3.2 Europe: OTC Drug Revenue Forecast (2021-2026)
12.3.3 Europe: OTC Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific OTC Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: OTC Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: OTC Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: OTC Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America OTC Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: OTC Drug Sales Forecast (2021-2026)
12.5.2 Latin America: OTC Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: OTC Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa OTC Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: OTC Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: OTC Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: OTC Drug Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key OTC Drug Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 OTC Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. OTC Drug Market Segments
Table 2. Ranking of Global Top OTC Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global OTC Drug Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Class A
Table 5. Major Manufacturers of Class B
Table 6. COVID-19 Impact Global Market: (Four OTC Drug Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for OTC Drug Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for OTC Drug Players to Combat Covid-19 Impact
Table 11. Global OTC Drug Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global OTC Drug Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global OTC Drug Sales by Regions 2015-2020 (K MT)
Table 14. Global OTC Drug Sales Market Share by Regions (2015-2020)
Table 15. Global OTC Drug Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global OTC Drug Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global OTC Drug Sales Share by Manufacturers (2015-2020)
Table 18. Global OTC Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global OTC Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Drug as of 2019)
Table 20. OTC Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. OTC Drug Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers OTC Drug Price (2015-2020) (USD/MT)
Table 23. OTC Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers OTC Drug Product Type
Table 25. Date of International Manufacturers Enter into OTC Drug Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global OTC Drug Sales by Type (2015-2020) (K MT)
Table 28. Global OTC Drug Sales Share by Type (2015-2020)
Table 29. Global OTC Drug Revenue by Type (2015-2020) (US$ Million)
Table 30. Global OTC Drug Revenue Share by Type (2015-2020)
Table 31. OTC Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global OTC Drug Sales by Application (2015-2020) (K MT)
Table 33. Global OTC Drug Sales Share by Application (2015-2020)
Table 34. North America OTC Drug Sales by Country (2015-2020) (K MT)
Table 35. North America OTC Drug Sales Market Share by Country (2015-2020)
Table 36. North America OTC Drug Revenue by Country (2015-2020) (US$ Million)
Table 37. North America OTC Drug Revenue Market Share by Country (2015-2020)
Table 38. North America OTC Drug Sales by Type (2015-2020) (K MT)
Table 39. North America OTC Drug Sales Market Share by Type (2015-2020)
Table 40. North America OTC Drug Sales by Application (2015-2020) (K MT)
Table 41. North America OTC Drug Sales Market Share by Application (2015-2020)
Table 42. Europe OTC Drug Sales by Country (2015-2020) (K MT)
Table 43. Europe OTC Drug Sales Market Share by Country (2015-2020)
Table 44. Europe OTC Drug Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe OTC Drug Revenue Market Share by Country (2015-2020)
Table 46. Europe OTC Drug Sales by Type (2015-2020) (K MT)
Table 47. Europe OTC Drug Sales Market Share by Type (2015-2020)
Table 48. Europe OTC Drug Sales by Application (2015-2020) (K MT)
Table 49. Europe OTC Drug Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific OTC Drug Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific OTC Drug Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific OTC Drug Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific OTC Drug Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific OTC Drug Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific OTC Drug Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific OTC Drug Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific OTC Drug Sales Market Share by Application (2015-2020)
Table 58. Latin America OTC Drug Sales by Country (2015-2020) (K MT)
Table 59. Latin America OTC Drug Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa OTC Drug Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America OTC Drug Revenue Market Share by Country (2015-2020)
Table 62. Latin America OTC Drug Sales by Type (2015-2020) (K MT)
Table 63. Latin America OTC Drug Sales Market Share by Type (2015-2020)
Table 64. Latin America OTC Drug Sales by Application (2015-2020) (K MT)
Table 65. Latin America OTC Drug Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa OTC Drug Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa OTC Drug Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa OTC Drug Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa OTC Drug Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa OTC Drug Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa OTC Drug Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa OTC Drug Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa OTC Drug Sales Market Share by Application (2015-2020)
Table 74. Bayer HealthCare Corporation Information
Table 75. Bayer HealthCare Description and Major Businesses
Table 76. Bayer HealthCare OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Bayer HealthCare Product
Table 78. Bayer HealthCare Recent Development
Table 79. GlaxoSmithKline (GSK) Corporation Information
Table 80. GlaxoSmithKline (GSK) Description and Major Businesses
Table 81. GlaxoSmithKline (GSK) OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. GlaxoSmithKline (GSK) Product
Table 83. GlaxoSmithKline (GSK) Recent Development
Table 84. Johnson&Johnson Corporation Information
Table 85. Johnson&Johnson Description and Major Businesses
Table 86. Johnson&Johnson OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Johnson&Johnson Product
Table 88. Johnson&Johnson Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Major Businesses
Table 91. Pfizer OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. Sanofi Corporation Information
Table 95. Sanofi Description and Major Businesses
Table 96. Sanofi OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Sanofi Product
Table 98. Sanofi Recent Development
Table 99. AstraZeneca Corporation Information
Table 100. AstraZeneca Description and Major Businesses
Table 101. AstraZeneca OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. AstraZeneca Product
Table 103. AstraZeneca Recent Development
Table 104. BioGaia Corporation Information
Table 105. BioGaia Description and Major Businesses
Table 106. BioGaia OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. BioGaia Product
Table 108. BioGaia Recent Development
Table 109. Bristol Myers Squibb Corporation Information
Table 110. Bristol Myers Squibb Description and Major Businesses
Table 111. Bristol Myers Squibb OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Bristol Myers Squibb Product
Table 113. Bristol Myers Squibb Recent Development
Table 114. Bukwang Pharmaceutica Corporation Information
Table 115. Bukwang Pharmaceutica Description and Major Businesses
Table 116. Bukwang Pharmaceutica OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Bukwang Pharmaceutica Product
Table 118. Bukwang Pharmaceutica Recent Development
Table 119. Chr. Hansen Corporation Information
Table 120. Chr. Hansen Description and Major Businesses
Table 121. Chr. Hansen OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Chr. Hansen Product
Table 123. Chr. Hansen Recent Development
Table 124. Cipla Corporation Information
Table 125. Cipla Description and Major Businesses
Table 126. Cipla OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Cipla Product
Table 128. Cipla Recent Development
Table 129. CoLucid Corporation Information
Table 130. CoLucid Description and Major Businesses
Table 131. CoLucid OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. CoLucid Product
Table 133. CoLucid Recent Development
Table 134. Daiichi Sankyo Corporation Information
Table 135. Daiichi Sankyo Description and Major Businesses
Table 136. Daiichi Sankyo OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Daiichi Sankyo Product
Table 138. Daiichi Sankyo Recent Development
Table 139. Friggs Corporation Information
Table 140. Friggs Description and Major Businesses
Table 141. Friggs OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Friggs Product
Table 143. Friggs Recent Development
Table 144. DSM Corporation Information
Table 145. DSM Description and Major Businesses
Table 146. DSM OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. DSM Product
Table 148. DSM Recent Development
Table 149. Eisai Corporation Information
Table 150. Eisai Description and Major Businesses
Table 151. Eisai OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. Eisai Product
Table 153. Eisai Recent Development
Table 154. Eli Lilly Corporation Information
Table 155. Eli Lilly Description and Major Businesses
Table 156. Eli Lilly OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 157. Eli Lilly Product
Table 158. Eli Lilly Recent Development
Table 159. Herbalife Corporation Information
Table 160. Herbalife Description and Major Businesses
Table 161. Herbalife OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 162. Herbalife Product
Table 163. Herbalife Recent Development
Table 164. Euradite Corporation Information
Table 165. Euradite Description and Major Businesses
Table 166. Euradite OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 167. Euradite Product
Table 168. Euradite Recent Development
Table 169. Global OTC Drug Sales Forecast by Regions (2021-2026) (K MT)
Table 170. Global OTC Drug Sales Market Share Forecast by Regions (2021-2026)
Table 171. Global OTC Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 172. Global OTC Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 173. North America: OTC Drug Sales Forecast by Country (2021-2026) (K MT)
Table 174. North America: OTC Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 175. Europe: OTC Drug Sales Forecast by Country (2021-2026) (K MT)
Table 176. Europe: OTC Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 177. Asia Pacific: OTC Drug Sales Forecast by Region (2021-2026) (K MT)
Table 178. Asia Pacific: OTC Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 179. Latin America: OTC Drug Sales Forecast by Country (2021-2026) (K MT)
Table 180. Latin America: OTC Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 181. Middle East and Africa: OTC Drug Sales Forecast by Country (2021-2026) (K MT)
Table 182. Middle East and Africa: OTC Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 183. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 184. Key Challenges
Table 185. Market Risks
Table 186. Main Points Interviewed from Key OTC Drug Players
Table 187. OTC Drug Customers List
Table 188. OTC Drug Distributors List
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
Table 1. OTC Drug Market Segments
Table 2. Ranking of Global Top OTC Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global OTC Drug Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Class A
Table 5. Major Manufacturers of Class B
Table 6. COVID-19 Impact Global Market: (Four OTC Drug Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for OTC Drug Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for OTC Drug Players to Combat Covid-19 Impact
Table 11. Global OTC Drug Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global OTC Drug Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global OTC Drug Sales by Regions 2015-2020 (K MT)
Table 14. Global OTC Drug Sales Market Share by Regions (2015-2020)
Table 15. Global OTC Drug Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global OTC Drug Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global OTC Drug Sales Share by Manufacturers (2015-2020)
Table 18. Global OTC Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global OTC Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Drug as of 2019)
Table 20. OTC Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. OTC Drug Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers OTC Drug Price (2015-2020) (USD/MT)
Table 23. OTC Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers OTC Drug Product Type
Table 25. Date of International Manufacturers Enter into OTC Drug Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global OTC Drug Sales by Type (2015-2020) (K MT)
Table 28. Global OTC Drug Sales Share by Type (2015-2020)
Table 29. Global OTC Drug Revenue by Type (2015-2020) (US$ Million)
Table 30. Global OTC Drug Revenue Share by Type (2015-2020)
Table 31. OTC Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global OTC Drug Sales by Application (2015-2020) (K MT)
Table 33. Global OTC Drug Sales Share by Application (2015-2020)
Table 34. North America OTC Drug Sales by Country (2015-2020) (K MT)
Table 35. North America OTC Drug Sales Market Share by Country (2015-2020)
Table 36. North America OTC Drug Revenue by Country (2015-2020) (US$ Million)
Table 37. North America OTC Drug Revenue Market Share by Country (2015-2020)
Table 38. North America OTC Drug Sales by Type (2015-2020) (K MT)
Table 39. North America OTC Drug Sales Market Share by Type (2015-2020)
Table 40. North America OTC Drug Sales by Application (2015-2020) (K MT)
Table 41. North America OTC Drug Sales Market Share by Application (2015-2020)
Table 42. Europe OTC Drug Sales by Country (2015-2020) (K MT)
Table 43. Europe OTC Drug Sales Market Share by Country (2015-2020)
Table 44. Europe OTC Drug Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe OTC Drug Revenue Market Share by Country (2015-2020)
Table 46. Europe OTC Drug Sales by Type (2015-2020) (K MT)
Table 47. Europe OTC Drug Sales Market Share by Type (2015-2020)
Table 48. Europe OTC Drug Sales by Application (2015-2020) (K MT)
Table 49. Europe OTC Drug Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific OTC Drug Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific OTC Drug Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific OTC Drug Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific OTC Drug Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific OTC Drug Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific OTC Drug Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific OTC Drug Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific OTC Drug Sales Market Share by Application (2015-2020)
Table 58. Latin America OTC Drug Sales by Country (2015-2020) (K MT)
Table 59. Latin America OTC Drug Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa OTC Drug Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America OTC Drug Revenue Market Share by Country (2015-2020)
Table 62. Latin America OTC Drug Sales by Type (2015-2020) (K MT)
Table 63. Latin America OTC Drug Sales Market Share by Type (2015-2020)
Table 64. Latin America OTC Drug Sales by Application (2015-2020) (K MT)
Table 65. Latin America OTC Drug Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa OTC Drug Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa OTC Drug Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa OTC Drug Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa OTC Drug Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa OTC Drug Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa OTC Drug Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa OTC Drug Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa OTC Drug Sales Market Share by Application (2015-2020)
Table 74. Bayer HealthCare Corporation Information
Table 75. Bayer HealthCare Description and Major Businesses
Table 76. Bayer HealthCare OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Bayer HealthCare Product
Table 78. Bayer HealthCare Recent Development
Table 79. GlaxoSmithKline (GSK) Corporation Information
Table 80. GlaxoSmithKline (GSK) Description and Major Businesses
Table 81. GlaxoSmithKline (GSK) OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. GlaxoSmithKline (GSK) Product
Table 83. GlaxoSmithKline (GSK) Recent Development
Table 84. Johnson&Johnson Corporation Information
Table 85. Johnson&Johnson Description and Major Businesses
Table 86. Johnson&Johnson OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Johnson&Johnson Product
Table 88. Johnson&Johnson Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Major Businesses
Table 91. Pfizer OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. Sanofi Corporation Information
Table 95. Sanofi Description and Major Businesses
Table 96. Sanofi OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Sanofi Product
Table 98. Sanofi Recent Development
Table 99. AstraZeneca Corporation Information
Table 100. AstraZeneca Description and Major Businesses
Table 101. AstraZeneca OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. AstraZeneca Product
Table 103. AstraZeneca Recent Development
Table 104. BioGaia Corporation Information
Table 105. BioGaia Description and Major Businesses
Table 106. BioGaia OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. BioGaia Product
Table 108. BioGaia Recent Development
Table 109. Bristol Myers Squibb Corporation Information
Table 110. Bristol Myers Squibb Description and Major Businesses
Table 111. Bristol Myers Squibb OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Bristol Myers Squibb Product
Table 113. Bristol Myers Squibb Recent Development
Table 114. Bukwang Pharmaceutica Corporation Information
Table 115. Bukwang Pharmaceutica Description and Major Businesses
Table 116. Bukwang Pharmaceutica OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Bukwang Pharmaceutica Product
Table 118. Bukwang Pharmaceutica Recent Development
Table 119. Chr. Hansen Corporation Information
Table 120. Chr. Hansen Description and Major Businesses
Table 121. Chr. Hansen OTC Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Chr. Hansen Product
Table 123. Chr. Hansen Recent Development
Table 124. Cipla Corporation Information
Table 125. Cipla Description and Major Businesses
Table 126. Cipla OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Cipla Product
Table 128. Cipla Recent Development
Table 129. CoLucid Corporation Information
Table 130. CoLucid Description and Major Businesses
Table 131. CoLucid OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. CoLucid Product
Table 133. CoLucid Recent Development
Table 134. Daiichi Sankyo Corporation Information
Table 135. Daiichi Sankyo Description and Major Businesses
Table 136. Daiichi Sankyo OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Daiichi Sankyo Product
Table 138. Daiichi Sankyo Recent Development
Table 139. Friggs Corporation Information
Table 140. Friggs Description and Major Businesses
Table 141. Friggs OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Friggs Product
Table 143. Friggs Recent Development
Table 144. DSM Corporation Information
Table 145. DSM Description and Major Businesses
Table 146. DSM OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. DSM Product
Table 148. DSM Recent Development
Table 149. Eisai Corporation Information
Table 150. Eisai Description and Major Businesses
Table 151. Eisai OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. Eisai Product
Table 153. Eisai Recent Development
Table 154. Eli Lilly Corporation Information
Table 155. Eli Lilly Description and Major Businesses
Table 156. Eli Lilly OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 157. Eli Lilly Product
Table 158. Eli Lilly Recent Development
Table 159. Herbalife Corporation Information
Table 160. Herbalife Description and Major Businesses
Table 161. Herbalife OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 162. Herbalife Product
Table 163. Herbalife Recent Development
Table 164. Euradite Corporation Information
Table 165. Euradite Description and Major Businesses
Table 166. Euradite OTC Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 167. Euradite Product
Table 168. Euradite Recent Development
Table 169. Global OTC Drug Sales Forecast by Regions (2021-2026) (K MT)
Table 170. Global OTC Drug Sales Market Share Forecast by Regions (2021-2026)
Table 171. Global OTC Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 172. Global OTC Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 173. North America: OTC Drug Sales Forecast by Country (2021-2026) (K MT)
Table 174. North America: OTC Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 175. Europe: OTC Drug Sales Forecast by Country (2021-2026) (K MT)
Table 176. Europe: OTC Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 177. Asia Pacific: OTC Drug Sales Forecast by Region (2021-2026) (K MT)
Table 178. Asia Pacific: OTC Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 179. Latin America: OTC Drug Sales Forecast by Country (2021-2026) (K MT)
Table 180. Latin America: OTC Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 181. Middle East and Africa: OTC Drug Sales Forecast by Country (2021-2026) (K MT)
Table 182. Middle East and Africa: OTC Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 183. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 184. Key Challenges
Table 185. Market Risks
Table 186. Main Points Interviewed from Key OTC Drug Players
Table 187. OTC Drug Customers List
Table 188. OTC Drug Distributors List
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. OTC Drug Product Picture
Figure 2. Global OTC Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Class A Product Picture
Figure 4. Class B Product Picture
Figure 5. Global OTC Drug Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Household
Figure 9. OTC Drug Report Years Considered
Figure 10. Global OTC Drug Market Size 2015-2026 (US$ Million)
Figure 11. Global OTC Drug Sales 2015-2026 (K MT)
Figure 12. Global OTC Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global OTC Drug Sales Market Share by Region (2015-2020)
Figure 14. Global OTC Drug Sales Market Share by Region in 2019
Figure 15. Global OTC Drug Revenue Market Share by Region (2015-2020)
Figure 16. Global OTC Drug Revenue Market Share by Region in 2019
Figure 17. Global OTC Drug Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by OTC Drug Revenue in 2019
Figure 19. OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global OTC Drug Sales Market Share by Type (2015-2020)
Figure 21. Global OTC Drug Sales Market Share by Type in 2019
Figure 22. Global OTC Drug Revenue Market Share by Type (2015-2020)
Figure 23. Global OTC Drug Revenue Market Share by Type in 2019
Figure 24. Global OTC Drug Market Share by Price Range (2015-2020)
Figure 25. Global OTC Drug Sales Market Share by Application (2015-2020)
Figure 26. Global OTC Drug Sales Market Share by Application in 2019
Figure 27. Global OTC Drug Revenue Market Share by Application (2015-2020)
Figure 28. Global OTC Drug Revenue Market Share by Application in 2019
Figure 29. North America OTC Drug Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America OTC Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America OTC Drug Sales Market Share by Country in 2019
Figure 32. North America OTC Drug Revenue Market Share by Country in 2019
Figure 33. U.S. OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America OTC Drug Market Share by Type in 2019
Figure 38. North America OTC Drug Market Share by Application in 2019
Figure 39. Europe OTC Drug Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe OTC Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe OTC Drug Sales Market Share by Country in 2019
Figure 42. Europe OTC Drug Revenue Market Share by Country in 2019
Figure 43. Germany OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 46. France OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe OTC Drug Market Share by Type in 2019
Figure 54. Europe OTC Drug Market Share by Application in 2019
Figure 55. Asia Pacific OTC Drug Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific OTC Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific OTC Drug Sales Market Share by Region in 2019
Figure 58. Asia Pacific OTC Drug Revenue Market Share by Region in 2019
Figure 59. China OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 60. China OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 66. India OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific OTC Drug Market Share by Type in 2019
Figure 82. Asia Pacific OTC Drug Market Share by Application in 2019
Figure 83. Latin America OTC Drug Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America OTC Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America OTC Drug Sales Market Share by Country in 2019
Figure 86. Latin America OTC Drug Revenue Market Share by Country in 2019
Figure 87. Mexico OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America OTC Drug Market Share by Type in 2019
Figure 94. Latin America OTC Drug Market Share by Application in 2019
Figure 95. Middle East and Africa OTC Drug Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa OTC Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa OTC Drug Sales Market Share by Country in 2019
Figure 98. Middle East and Africa OTC Drug Revenue Market Share by Country in 2019
Figure 99. Turkey OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa OTC Drug Market Share by Type in 2019
Figure 106. Middle East and Africa OTC Drug Market Share by Application in 2019
Figure 107. Bayer HealthCare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. GlaxoSmithKline (GSK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Johnson&Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. BioGaia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Bukwang Pharmaceutica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Chr. Hansen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. CoLucid Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Friggs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. DSM Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Herbalife Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. Euradite Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. North America OTC Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 127. North America OTC Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Europe OTC Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 129. Europe OTC Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Asia Pacific OTC Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 131. Asia Pacific OTC Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Latin America OTC Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 133. Latin America OTC Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 134. Middle East and Africa OTC Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 135. Middle East and Africa OTC Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 136. Porter's Five Forces Analysis
Figure 137. Channels of Distribution
Figure 138. Distributors Profiles
Figure 139. Bottom-up and Top-down Approaches for This Report
Figure 140. Data Triangulation
Figure 141. Key Executives Interviewed
Figure 1. OTC Drug Product Picture
Figure 2. Global OTC Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Class A Product Picture
Figure 4. Class B Product Picture
Figure 5. Global OTC Drug Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Household
Figure 9. OTC Drug Report Years Considered
Figure 10. Global OTC Drug Market Size 2015-2026 (US$ Million)
Figure 11. Global OTC Drug Sales 2015-2026 (K MT)
Figure 12. Global OTC Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global OTC Drug Sales Market Share by Region (2015-2020)
Figure 14. Global OTC Drug Sales Market Share by Region in 2019
Figure 15. Global OTC Drug Revenue Market Share by Region (2015-2020)
Figure 16. Global OTC Drug Revenue Market Share by Region in 2019
Figure 17. Global OTC Drug Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by OTC Drug Revenue in 2019
Figure 19. OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global OTC Drug Sales Market Share by Type (2015-2020)
Figure 21. Global OTC Drug Sales Market Share by Type in 2019
Figure 22. Global OTC Drug Revenue Market Share by Type (2015-2020)
Figure 23. Global OTC Drug Revenue Market Share by Type in 2019
Figure 24. Global OTC Drug Market Share by Price Range (2015-2020)
Figure 25. Global OTC Drug Sales Market Share by Application (2015-2020)
Figure 26. Global OTC Drug Sales Market Share by Application in 2019
Figure 27. Global OTC Drug Revenue Market Share by Application (2015-2020)
Figure 28. Global OTC Drug Revenue Market Share by Application in 2019
Figure 29. North America OTC Drug Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America OTC Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America OTC Drug Sales Market Share by Country in 2019
Figure 32. North America OTC Drug Revenue Market Share by Country in 2019
Figure 33. U.S. OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America OTC Drug Market Share by Type in 2019
Figure 38. North America OTC Drug Market Share by Application in 2019
Figure 39. Europe OTC Drug Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe OTC Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe OTC Drug Sales Market Share by Country in 2019
Figure 42. Europe OTC Drug Revenue Market Share by Country in 2019
Figure 43. Germany OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 46. France OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe OTC Drug Market Share by Type in 2019
Figure 54. Europe OTC Drug Market Share by Application in 2019
Figure 55. Asia Pacific OTC Drug Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific OTC Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific OTC Drug Sales Market Share by Region in 2019
Figure 58. Asia Pacific OTC Drug Revenue Market Share by Region in 2019
Figure 59. China OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 60. China OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 66. India OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific OTC Drug Market Share by Type in 2019
Figure 82. Asia Pacific OTC Drug Market Share by Application in 2019
Figure 83. Latin America OTC Drug Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America OTC Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America OTC Drug Sales Market Share by Country in 2019
Figure 86. Latin America OTC Drug Revenue Market Share by Country in 2019
Figure 87. Mexico OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America OTC Drug Market Share by Type in 2019
Figure 94. Latin America OTC Drug Market Share by Application in 2019
Figure 95. Middle East and Africa OTC Drug Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa OTC Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa OTC Drug Sales Market Share by Country in 2019
Figure 98. Middle East and Africa OTC Drug Revenue Market Share by Country in 2019
Figure 99. Turkey OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E OTC Drug Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E OTC Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa OTC Drug Market Share by Type in 2019
Figure 106. Middle East and Africa OTC Drug Market Share by Application in 2019
Figure 107. Bayer HealthCare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. GlaxoSmithKline (GSK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Johnson&Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. BioGaia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Bukwang Pharmaceutica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Chr. Hansen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. CoLucid Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Friggs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. DSM Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Herbalife Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. Euradite Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. North America OTC Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 127. North America OTC Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Europe OTC Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 129. Europe OTC Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Asia Pacific OTC Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 131. Asia Pacific OTC Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Latin America OTC Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 133. Latin America OTC Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 134. Middle East and Africa OTC Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 135. Middle East and Africa OTC Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 136. Porter's Five Forces Analysis
Figure 137. Channels of Distribution
Figure 138. Distributors Profiles
Figure 139. Bottom-up and Top-down Approaches for This Report
Figure 140. Data Triangulation
Figure 141. Key Executives Interviewed
